Literature DB >> 12086308

Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity.

R H Swanborg1.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) in the rat is an acute paralytic disease from which most animals spontaneously recover. The disease can be induced in susceptible inbred Lewis and DA rats with myelin basic protein (MBP), or encephalitogenic MBP peptides administered in complete Freund's adjuvant (CFA). The disease can be adoptively transferred to syngeneic recipients with primed T cells that have been reactivated in vitro with antigen. EAE is mediated by CD4+ Th1 cells that secrete proinflammatory cytokines, and spontaneous remission is associated with CD4+ T cells that secrete transforming growth factor-beta (TGF-beta). Studies of EAE in susceptible rats have provided many important insights into the interactions of T cells and accessory cells that culminate in the induction of the autoimmune response.

Entities:  

Mesh:

Year:  2001        PMID: 12086308     DOI: 10.1034/j.1600-065x.2001.1840112.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  33 in total

1.  The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.

Authors:  Emilia Solomon; Hui Li; Sara Duhachek Muggy; Emilia Syta; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 2.  Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.

Authors:  David Luckey; Dikshya Bastakoty; Ashutosh K Mangalam
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

Review 3.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 4.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

5.  Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions.

Authors:  Rashida Ginwala; Emily McTish; Chander Raman; Narendra Singh; Mitzi Nagarkatti; Prakash Nagarkatti; Divya Sagar; Pooja Jain; Zafar K Khan
Journal:  J Neuroimmune Pharmacol       Date:  2015-06-04       Impact factor: 4.147

Review 6.  The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.

Authors:  Andrew P Robinson; Christopher T Harp; Avertano Noronha; Stephen D Miller
Journal:  Handb Clin Neurol       Date:  2014

7.  Nogo-A at CNS paranodes is a ligand of Caspr: possible regulation of K(+) channel localization.

Authors:  Du-Yu Nie; Zhi-Hong Zhou; Beng-Ti Ang; Felicia Y H Teng; Gang Xu; Tao Xiang; Chao-Yang Wang; Li Zeng; Yasuo Takeda; Tian-Le Xu; Yee-Kong Ng; Catherine Faivre-Sarrailh; Brian Popko; Eng-Ang Ling; Melitta Schachner; Kazutada Watanabe; Catherine J Pallen; Bor Luen Tang; Zhi-Cheng Xiao
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

8.  Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.

Authors:  K Mangano; A Nicoletti; F Patti; M Donia; L Malaguarnera; S Signorelli; G Magro; V Muzio; B Greco; P Zaratin; P Meroni; M Zappia; F Nicoletti
Journal:  Clin Exp Immunol       Date:  2009-11-18       Impact factor: 4.330

9.  Bladder dysfunction in mice with experimental autoimmune encephalomyelitis.

Authors:  Cengiz Z Altuntas; Firouz Daneshgari; Guiming Liu; Adebola Fabiyi; Michael Kavran; Justin M Johnson; M Fatih Gulen; Ritika Jaini; Xiaoxia Li; Tara L Frenkl; Vincent K Tuohy
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

10.  IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis.

Authors:  Erin E McCandless; Matthew Budde; Jason R Lees; Denise Dorsey; Eric Lyng; Robyn S Klein
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.